Project Grant 2432785
Award Date
5/1/25
Completion Date
4/30/26
Dollars Obligated
$275K
Federal Agency
National Science Foundation
Awardee
Vivosphere LLC (QSAGDTU231N8)
Federal Grant Program
47.084
Assistance Type
Project Grant
Place of Performance
Auburn, AL 36832, USA
Similar Awards
The federal Project Grant award of $350,000 was provided by the National Center for Advancing Translational Sciences (NCATS), under the CFDA Program 93.350, to Vivosphere LLC in Auburn, AL. The funding will support the development of "Vivospheres", which are tissue-engineered spheroidal models for high-throughput screening. The project aims to establish Vivospheres as a more consistent and flexible 3D cell culture system compared to traditional self-aggregation methods, enabling...
This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Project Grant award of $275,000 to Cerflux Inc. aims to develop a personalized cancer treatment screening platform. The project will establish guidelines for handling solid tumor biopsy samples, generate 3D bioprinted tumor models for validation, and demonstrate the platform's ability to match patients with the most effective cancer treatments before treatment begins. This innovative approach has the...
This National Science Foundation Project Grant of $255,995 supported Encapsulate Inc. to develop an automated biochip platform for personalized cancer screening under the NSF Technology, Innovation, and Partnerships program (CFDA 47.084). The award period was from May 15, 2022 to April 30, 2023.
The platform will grow patient-derived cancer cells outside the body on biochips to screen them against chemotherapy drugs. This addresses the problem that over 70% of cancer patients undergo...
This Project Grant award from the National Science Foundation's (NSF) Computer and Information Science and Engineering (CISE) program (CFDA 47.070) is funding the development of an engineered cyber-physical system to accurately predict patient responses to anti-cancer therapies. The $275,956 award to the University of Massachusetts Lowell will leverage expertise in biofabrication, tissue engineering, microfluidics, bioanalysis, and artificial intelligence to construct biomimetic, vascularized...
This $274,594 Project Grant award from the National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) program supports research and development of an innovative technology for cancer diagnosis and treatment. The project aims to improve molecular profiling and clinical laboratory testing of cancer samples by optimizing microdissection techniques. The research will focus on modeling and optimizing the opto-thermal-mechanical interactions involved in microdissection...
This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Project Grant award provides $275,000 to Oncoblaze LLC to develop a novel device for the targeted delivery of chemotherapy agents to tissue surrounding surgically removed tumors. The device utilizes an infrared laser to precisely heat targeted tissue regions to trigger the release of encapsulated chemotherapy from heat-sensitive lipid particles. The project aims to (1) build and test a device...
The National Science Foundation (NSF) awarded a $275,000 Small Business Innovation Research (SBIR) Phase I grant under the NSF Technology, Innovation, and Partnerships (CFDA 47.084) program to 37Degrees, Inc., a for-profit organization located in Geneva, IL. The project aims to develop a portable and modular system for long-term live cell and tissue culture imaging, enabling affordable and accessible cellular video microscopy for scientists. Key technical objectives include creating a compact...
This National Science Foundation Project Grant of $606,649 will support the development of an engineered cyber-physical system combining advanced biological models and artificial intelligence methods to enable precision medicine for cancer treatment. Awarded under the Computer and Information Science and Engineering program, the funding will be used by Brigham and Women's Hospital and its parent organization Partners Healthcare System from October 2022 to September 2025. Specifically, the...
This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Project Grant of $274,829 awarded to Rosebud Biosciences Inc. on August 15, 2023 aims to enable the development of new therapies for rare diseases in children. The project objectives are to: (1) Automate the derivation of heart, liver, and brain organoids from human stem cells, and (2) Develop automated machine learning models to detect disease phenotypes in these organoids derived from patients with...
This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Project Grant award of $274,811 to Anova Biomedical, Inc. aims to develop a novel 3D printing resin for the production of personalized, elastic, and bioresorbable vascular grafts. The key objectives include: 1) Developing, characterizing, and optimizing the resin formulation, 2) Demonstrating the ability to 3D print personalized vascular grafts using patient CT angiography data, and 3) Implanting the...